Ignite Creation Date:
2025-12-24 @ 9:33 PM
Ignite Modification Date:
2025-12-25 @ 7:17 PM
Study NCT ID:
NCT01198132
Status:
COMPLETED
Last Update Posted:
2017-12-14
First Post:
2010-09-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-11
Start Date Type:
ACTUAL
Primary Completion Date:
2015-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-08
First Submit QC Date:
None
Study First Post Date:
2010-09-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-06
Results First Submit QC Date:
None
Results First Post Date:
2017-12-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-09
Last Update Post Date:
2017-12-14
Last Update Post Date Type:
ACTUAL